With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

Terrana is aiming to have commercially available products in the next few years, pending regulatory approval, that can be applied as sprayables or seed treatments. And the company says its RNA-based ...

Ranjan Narula and Shakti Priyan Nair of RNA, Technology and IP Attorneys examine how Indian law and recent court rulings have ...

Terrana Biosciences will develop crop protection inputs using RNA technology, which was used by Flagship portfolio company ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 18.72% over the forecast period ...

MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer.

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...